Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
5,861,399
-
Shares change
-
-274,484
-
Total reported value, excl. options
-
$23,444,000
-
Value change
-
-$1,111,881
-
Number of buys
-
5
-
Number of sells
-
-17
-
Price
-
$4.00
Significant Holders of KEMPHARM INC - COM (KMPH) as of Q2 2017
32 filings reported holding KMPH - KEMPHARM INC - COM as of Q2 2017.
KEMPHARM INC - COM (KMPH) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,861,399 shares
.
Largest 10 shareholders include DSC Advisors, L.P. (1,459,193 shares), Alyeska Investment Group, L.P. (974,617 shares), Arete Wealth Advisors, LLC (851,978 shares), DEERFIELD MANAGEMENT CO (704,612 shares), Creative Planning (453,523 shares), C WorldWide Group Holding A/S (381,699 shares), VANGUARD GROUP INC (249,117 shares), FEDERATED INVESTORS INC /PA/ (160,000 shares), VICTORY CAPITAL MANAGEMENT INC (130,573 shares), and Parkwood LLC (125,809 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.